Partner Headlines - IRWD

  1. Ironwood Presents IW-9179 Phase IIa Data At American College ...

    Benzinga
  2. Ardelyx Bowel Drug Could Rival Actavis' Linzess

    IBD
  3. Markets Open Higher; VeriFone Profit Tops Street View

    Benzinga
  4. Benzinga's Top Downgrades

    Benzinga
  5. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga
  6. Ironwood Pharmaceuticals Announces $150M Proposed Public Offering ...

    Benzinga
  7. Mid-Day Market Update: Dow Tumbles Over 100 Points; Signature ...

    Benzinga
  8. Mid-Morning Market Update: Markets Mixed; Verizon Posts Q4 Profit

    Benzinga
  9. Weekly 3-Year Low Highlight: EXC, RVBD, IRWD, SHOS

    GuruFocus
  10. UPDATE: Cowen & Company Upgraded Ironwood Pharmaceuticals

    Benzinga
  11. Five-Year Lows: Singapore Airlines Limited, Gold Field Ltd., ...

    GuruFocus
  12. Stocks Hitting 52-Week Lows

    Benzinga
  13. Earnings Scheduled For January 15, 2013

    Benzinga
  14. Ironwood Starts Phase I Trial of Anti-Anxiety Drug in US

    Benzinga
  15. Weekly CEO Buys Highlight: GDOT, VOCS, PES, IRWD, ABR

    GuruFocus
  16. Ironwood Pharmaceuticals, Inc. (IRWD) CEO Peter M Hecht buys ...

    GuruFocus
  17. Ironwood and AstraZeneca Announce Linaclotide Collaboration for ...

    Benzinga
  18. Ironwood and Forest Announce FDA Approval of LINZESSTM

    Benzinga
  19. UPDATE: Cantor Fitzgerald Raises PT to $8 on Ironwood Pharmaceuticals; ...

    Benzinga
  20. Biotechs With Upcoming PDUFA Dates

    Benzinga
  21. UPDATE: Wedbush Downgrades Ironwood Pharmaceuticals; Lowers PT

    Benzinga
  22. Bank of America: Zelnorm vs. linaclotide

    Benzinga
  23. Ironwood Pharmaceuticals Announces Exercise of Over-Allotment ...

    Benzinga
  24. From Earlier: Ironwood Pharmaceuticals Prices Public Offering ...

    Benzinga
  25. Ironwood Pharmaceuticals Announces Proposed Public Offering of ...

    Benzinga
  26. Ironwood Pharmaceuticals and Bionomics Announce Collaboration, ...

    Benzinga
  27. European Patent Office Upholds Synergy Pharmaceuticals' Grant ...

    Benzinga
Trading Center